1. World Health Organization. Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. Wkly Epidemiol Rec. 2002; 77(40):331–9.
2. Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, et al.Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis. 2013; 19(4):566–73. doi: http://dx.doi.org/10.3201/eid1904.111799 .
3. Public Health Agency of Canada. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005. Can Commun Dis Rep. 2007; 33(1481–8531 (Electronic)):1–15.
4. Ines Agudelo C, Sanabria OM, Ovalle MV. Serogroup Y meningococcal disease, Colombia. Emerg Infect Dis. 2008; 14(6):990–1. doi: http://dx.doi.org/10.3201/eid1406.071357 .
5. Ciccone FH, Suzuki E, Pellini A. Meningococcal disease: communitarian outbreak investigation in Grajau, in the city of Sao Paulo. BEPA. 2006; 3:7–12.